Crystagen
Also known as: Immune peptide bioregulator · Immune-system bioregulator
An immune-system peptide bioregulator studied in Russian research for immune-related markers in aging.
Crystagen at a glance
| Name | Crystagen |
|---|---|
| Also known as | Immune peptide bioregulator, Immune-system bioregulator |
| Category | Immune support |
| Type | Peptide |
| Sequence | Short synthetic peptide bioregulator |
| Typical dose | Commonly cited around 1-3 mg per short course |
| Frequency | Short cyclical courses in the discussed protocols |
| Route | Subcutaneous or intramuscular injection (research); oral capsule forms also marketed |
| Half-life | Not well established. |
Overview
Crystagen is described in the bioregulator literature as a short synthetic immune-oriented peptide, positioned as a general immune-system regulator within the Khavinson framework. It is discussed for proposed effects on immune-cell activity and immune balance during aging, overlapping conceptually with the thymic bioregulators. The supporting evidence is largely in-house, older, and non-Western, and independent replication in mainstream immunology is lacking.
How it’s thought to work
- Proposed to act as an immune-oriented peptide bioregulator influencing gene expression in immune cells.
- Studied for effects on immune-cell activity and cytokine-related markers.
- Mechanistic claims rest largely on the originating group's work and are not independently well established.
Researched uses
- Immune support in aging models
- General immune-balance research interest
- Cited in longevity-peptide and immune-function discussions
Commonly cited protocol
| Typical dose | Commonly cited around 1-3 mg per short course |
|---|---|
| Frequency | Short cyclical courses in the discussed protocols |
| Route | Subcutaneous or intramuscular injection (research); oral capsule forms also marketed |
| Notes | Typically described in cycles in the source literature. |
Reconstitution
Commonly a 5-10 mg vial; reconstitute with bacteriostatic water and use the calculator for units.
Crystagen dosage calculator
The calculator below is pre-filled with Crystagen’s commonly cited vial size and dose. Adjust the vial amount, bacteriostatic water, or dose to match your own vial — it will show the exact insulin-syringe units to draw, the concentration, and how many doses the vial holds.
Add 2 mL of bacteriostatic water to your 10 mg vial. That gives you about 5 doses of 2 mg. For each dose, draw 40 units into a 100-unit insulin syringe.
See the full Crystagen dosing chart (units for every dose & water amount), or open the full peptide calculator →
Cautions
- Not FDA-approved; a research compound, not an approved immune therapy.
- The evidence base is limited, older, and largely non-Western, and has not been widely replicated.
- Purity of research-grade material varies by source.
- Immune conditions should be managed with a qualified clinician rather than self-directed peptide use.
Crystagen FAQ
What is Crystagen?
An immune-system peptide bioregulator studied in Russian research for immune-related markers in aging.
How does Crystagen work?
Proposed to act as an immune-oriented peptide bioregulator influencing gene expression in immune cells. Studied for effects on immune-cell activity and cytokine-related markers. Mechanistic claims rest largely on the originating group's work and are not independently well established.
What is Crystagen used for?
Immune support in aging models; General immune-balance research interest; Cited in longevity-peptide and immune-function discussions.
What is a typical Crystagen dose?
Commonly cited around 1-3 mg per short course, Short cyclical courses in the discussed protocols, Subcutaneous or intramuscular injection (research); oral capsule forms also marketed. This is a commonly cited figure for context only, not medical advice.
How do you reconstitute Crystagen?
Commonly a 5-10 mg vial; reconstitute with bacteriostatic water and use the calculator for units.
What is the half-life of Crystagen?
Not well established.